| Wiki Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Stocks Mutual Funds > The 4 Worst Things You Can Do As An Investor |
|
Wiki Articles - The 4 Worst Things You Can Do As An Investor
Number one: don't stop reading. Too many investors see these common failures and simply brush past them, thinking "How co According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product uld I possibly fall into the category of the average investor? I'm smarter than all of this; I can't be subject to these ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in kinds of mistakes..." ...WRONG More investments go sour from these different 'mistakes' than any other obstacle you'll lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. face in your investing career. So please, do yourself a favor and keep reading. And keep an open mind too. Number two is here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe fear. There are two ends to the spectrum here so you have to find a middle ground. The most common is being afraid of cut d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ting your losses. Don't stay in simply hoping it will get better, or you'll dig yourself a much deeper hole. What's worse ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is being afraid to make any mistakes at all. This has kept many of us from jumping into a sound investment. Just keep in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi mind that you won't be able to win if you're not even playing the game. The second half of this is not fearing anything. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Having that little voice of reason in your head can keep you from throwing away a lot of money. If this sounds like you, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ you're cure is risk management. Take the necessary precautions to set explicit limits as to when you get out of any inve ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tment, no matter the outcome. Follow the rules you set for yourself to keep your investing safe. Next on the list: ignor ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ance. I can't believe how eager people are to jump into the system and try to start making money without learning the gam dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e. You need to have a passion for learning everything in the market. By studying what you're up against and becoming know cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ledgeable about what you're doing specifically you'll have a far greater advantage than any other trader. The big step: tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen igure out what you do and don't know. It's harder than it sounds but by doing so you'll give yourself an honest approach t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to making yourself better. Finally we come down to an investor's greatest enemy: greed. People are gullible...YOU are gu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust llible. Too many people get sucked into the "miracle investment" that promises the amazing returns while hiding the major y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products risks. Do your homework. If you take care of your professional ignorance above, greed should never get the best of you. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de It's your money we're talking about here. You should be able to look at each investment objectively to ensure your financ elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ial safety. Armed with these easy techniques you'll be able to become a major player in the world of investing in no time tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Four Easy Steps To Building A Powerful Employee Incentive Program Free Giveaway Ebooks - Use to Create Traffic Link Building Strategies; Part 1
|